 | Up a level |
Journal Article
Goereci, Y., Schweitzer, F., Wellstein, A., Silling, S., Borchmann, S., von Tresckow, B., Adams, O., Martin, R., Schlamann, M., Schroeter, M., Fink, G. R., Wattjes, M. P. and Warnke, C. (2020). Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome. Eur. J. Neurol., 27 (11). S. 2375 - 2378. HOBOKEN: WILEY. ISSN 1468-1331
Ladwig, A., Suh, J., Schweitzer, F., Roeth, P., Remke, G., Warnke, C., Schroeter, M., Izquierdo-Alvarez, E., Bonmann, E., Fink, G. R., Pallasch, C. and Lehmann, H. (2020). Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis. Mult. Scler. J., 26 (3_SUPPL). S. 259 - 260. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Schweitzer, F., Ladwig, A., Laurent, S., Schroeter, M., Goelz, S., Wieland, U., Silling, S. and Warnke, C. (2020). Is the gut a relevant reservoir for persistent jcpyv infection? Mult. Scler. J., 26 (3_SUPPL). S. 286 - 288. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Schweitzer, F., Laurent, S., Fink, G. R., Barnett, Michael H., Hartung, H. P. and Warnke, C. . Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis. J. Neurol.. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1459
Schweitzer, F., Pfeifer, N., Kaiser, R., Jensen, B., Faetkenheuer, G., Esser, S. and Trapp, S. (2014). Model to investigate host-specific innate and adaptive immune responses in therapy-naive HIV-1 infected patients. Antivir. Ther., 19. S. A158 - 1. LONDON: INT MEDICAL PRESS LTD. ISSN 1359-6535
Teutsch, K., Schweitzer, F., Knops, E., Kaiser, R., Pfister, H., Verheyen, J., Goebel, H., Cingoez, T. and Di Cristanziano, V. (2015). Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy. Med. Microbiol. Immunol., 204 (6). S. 657 - 665. NEW YORK: SPRINGER. ISSN 1432-1831